Abstract
An intricate relationship between impaired immune functions and the age-related accumulation of tissue senescent cells is rapidly emerging. The immune system is unique as it undergoes mutually inclusive and deleterious processes of immunosenescence and cellular senescence with advancing age. While factors inducing immunosenescence and cellular senescence may be shared, however, both these processes are fundamentally different which holistically influence the aging immune system. Our understanding of the biological impact of immunosenescence is relatively well-understood, but such knowledge regarding cellular senescence in immune cells, especially in the innate immune cells such as macrophages, is only beginning to be elucidated. Tissue-resident macrophages are long-lived, and while functioning in tissue-specific and niche-specific microenvironments, senescence in macrophages can be directly influenced by senescent host cells which may impact organismal aging. In addition, evidence of age-associated immunometabolic changes as drivers of altered macrophage phenotype and functions such as inflamm-aging is also emerging. The present review describes the emerging impact of cellular senescence vis-à-vis immunosenescence in aging macrophages, its biological relevance with other senescent non-immune cells, and known immunometabolic regulators. Gaps in our present knowledge, as well as strategies aimed at understanding cellular senescence and its therapeutics in the context of macrophages, have been reviewed.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The last decade has seen rapid progress in our understanding of the molecular etiology and pathological effects of aging. There is increasing evidence that the stochastic phenomenon of aging is essentially a culmination of cellular and molecular damage over time that gradually manifests as the visible macrophenotype of aging (Bhatia-Dey et al. 2016; Chandrasekaran et al. 2017). Several different theories were formulated to explain the causes and mechanisms of aging, but gerontologists are now showing considerable interest in the cellular senescence centric interpretation of aging which is beginning to uncover an integrative and tangible understanding of the known effects of aging (Dodig et al. 2019; Borghesan et al. 2020). Aging itself is not a disease, but it rather predisposes the elderly to several age-associated disorders including the characteristic hallmark diseases of the twenty first century, i.e., cancer and diabetes (Huo et al. 2018; DeSantis et al. 2019). In fact, a view is now emerging that the various age-related diseases should be studied in the purview of cellular senescence and that targeting cellular senescence itself could be a novel approach in preventing frailty and the aggravation of several age-associated disorders (Wijshake and van Deursen 2016; Borghesan et al. 2020). This is supported by multiple studies which have demonstrated that accumulation of senescent cells (SC) shorten healthspan and lifespan (Baker et al. 2016), and that delaying the development of cellular senescence (Sharma et al. 2021) or lifelong removal of SC can enhance longevity (Baker et al. 2011), improve tissue regeneration (Krishnamurthy et al. 2006), and prevent the development of chronic age-associated disorders (Lewis-McDougall et al. 2019; Palmer et al. 2019; Cai et al. 2020; Ogrodnik et al. 2021). In fact, the targeted removal of SC using senolytics is an emerging area of research, and active preclinical search, as well as clinical assessment of putative senolytics is presently underway (Xu et al. 2018; Hickson et al. 2019; Wissler Gerdes et al. 2020).
The immune system is a complex, yet coordinated and highly plastic network of cells that has been traditionally recognized to protect the integrity of the organism from invading pathogens. However, it is now understood that the pattern recognition receptors of immune cells not only recognize the pathogen-associated molecular patterns but also respond to cell-intrinsic damage-associated molecular patterns or DAMPs suggesting their broader and more significant physiological role (Mogensen 2009). The innate and adaptive branches of the immune system communicate either directly or through a variety of signaling molecules, while the integrated neuroendocrine-immune system governs the interactions between immune cells and other regulatory systems. As observed with different physiological responses, the immune system also undergoes characteristic functional and phenotypical deterioration with age resulting in feeble response to pathogens and vaccination, and the development of chronic age-associated inflamm-aging (Aw et al. 2007; Del Giudice et al. 2017; Aiello et al. 2019; Xu et al. 2020). These changes have been loosely described as ‘immunosenescence’, although the exact biomarkers of immunosenescence and that whether this process is the cause or a consequence of aging itself is still debatable (Pawelec et al. 2020). Regardless, aging in immune cells has traditionally been considered within the purview of immunosenescence; however, similar to other mammalian cells, immune cells are also liable to be affected by the different facets of cellular senescence which can have a potentially deleterious impact on immune functions (Vicente et al. 2016). Although the triggers of immunosenescence and cellular senescence may overlap, both these processes show fundamentally distinct characteristics and yet have the potential to impair immune functions with age (Burton and Stolzing 2018) (Table 1). However, unlike immunosenescence, our understanding of the role, and particularly the biological impact of cellular senescence in immune cells is only emerging. This is especially relevant for innate immune cells such as macrophages which form the basis of parenchymal homeostasis, integrity, and perform unique tissue-specific functions as resident immune cells. This review describes our current understanding and relevance of cellular senescence in immune cells per se, with an emphasis on macrophages. The lacunae in our present knowledge, as well as the potential for further research are discussed to ultimately understand how cellular senescence contributes to the macrophage aging process.
Cellular senescence, immunity, and aging: emerging concepts
The fact that mitotic mammalian cells fail to divide after a certain finite number of cell divisions in vitro (replicative senescence) was a seminal discovery in biogerontology (Hayflick and Moorhead 1961; Rattan 2016). The so-called ‘Hayflick limit’ seemingly provided a link between cell division and organismal aging, but this phenomenon remained controversial and was initially dismissed as a mere in vitro artifact (Hayflick 1998; de Magalhães 2004). However, multiple studies have now confirmed that SC play a causal role in governing organismal aging and age-dependent disorders (Campisi and Robert 2014; Childs et al. 2015; Katzir et al. 2021), and in fact, cellular senescence is established as one of the well-studied hallmarks of aging (López-Otín et al. 2013). In general, cellular senescence is characterized by cellular hypertrophy, permanent cell cycle arrest by the activation of cell cycle inhibitory pathways such as p53/p21WAF1 and/or p16Ink4a/pRb, chromatin remodeling, resistance to apoptosis by deregulation of Bax/Bcl-2 signaling, telomere attrition, development of a senescence-associated secretory phenotype or SASP, and altered metabolic longevity pathways such as SIRT and mTOR (Carroll and Korolchuk 2018; Hernandez-Segura et al. 2018; Kumari and Jat 2021; Maduro et al. 2021). The induction of cellular senescence is intimately linked to external and intrinsic cell stressors. A decline in cellular stress response capacity results in impaired redox balance, augmentation of genotoxic stress, and DNA damage that ultimately aids in cell cycle arrest and the development of cellular senescence (Nacarelli et al. 2016; Zhang et al. 2017; Robinson et al. 2018; Chen et al. 2020). Moreover, there is evidence that the characteristic telomere attrition, as observed during replicative senescence, could also be accelerated by oxidative damage (von Zglinicki 2002; Ludlow et al. 2014). However, it is important to consider that SC are naturally occurring cells and their presence per se does not reflect on the pathological state of the organism, since SC are essential mediators of processes such as wound healing and repair (Demaria et al. 2014). In younger organisms, SC are constantly replaced, but as we age, SC turnover decreases, and tissue SC burden rapidly increases which contributes to age-related pathologies (Karin et al. 2019). More significantly, the accumulation of SC result in the chronic presence of SASP which has pro-tumorigenic and pro-inflammatory paracrine effects on nearby healthier cells (Coppé et al. 2010). Due to this, the SASP is being considered as a potent source of ‘inflamm-aging’-which is a chronic and heightened state of inflammatory stimulus that augments inflammatory disorders in aging population (Fulop et al. 2016; Olivieri et al. 2018). Thus, cellular senescence appears to be an antagonistic hallmark of aging and a candidate example of the antagonistic pleiotropy theory of aging.
The exact causes of SC accumulation with age are yet to be completely understood. In this regard, the role of immune cells in maintaining SC cell homeostasis in tissues is being increasingly recognized (Prata et al. 2018; Kale et al. 2020). The SASP components of SC serve to chemotactically attract various immune cells such as macrophages, NK cells, and cytotoxic T cells which subsequently recognize the upregulated immunogenic ligands on SC (such as MICA and ULBP2) resulting in their efficient removal (Coppé et al. 2010; Hall et al. 2016; Sagiv et al. 2016) (Fig. 1). That SC accumulate in aging organisms, could at least in part be ascribed to deficient immune functions/immunosurveillance associated with immunosenescence and/or cellular senescence (Fig. 1). Indeed, a recent work demonstrated that mice deficient in the cytotoxic potential of immune cells exhibited both higher SC tissue burden and chronic inflammation suggesting that weakened immunosurveillance could be a critical aspect regulating SC accumulation in vivo (Ovadya et al. 2018). Another study showed that impaired immunosurveillance in CD4+ T cells results in the development of murine hepatocellular carcinomas, thus suggesting that senescence surveillance is important for tumor suppression in vivo (Kang et al. 2011). Similarly, it was reported that NK cells play a critical role in eliminating senescence-activated stellate hepatic cells both in vitro and in vivo (Krizhanovsky et al. 2008). The role of macrophages in the removal of SC has long been speculated (Kay 1975; Mevorach et al. 2010). Using a co-culture system, a recent study showed that macrophages can induce TNF-α mediated apoptosis in senescent fibroblasts followed by their phagocytic clearance (Ogata et al. 2021). Macrophages are also involved in the elimination of SC in the uterine stroma surrounding the embryo implantation site following parturition in mice (Egashira et al. 2017). In addition, the SASP of senescent hepatic cells not only attracts macrophages (Irvine et al. 2014) but also influences the M1/M2 polarization state of macrophages (Lujambio et al. 2013). It is also interesting to note that SC themselves can also develop features of immune evasion. It was demonstrated that SC can escape the immune system by upregulating the expression of non-classical MHC molecule HLA-E, which inhibits NK cells and CD8+ T cells mediated immune responses against SC, thereby aiding in inefficient removal and accumulation of SC (Pereira et al. 2019). This potentially suggests autonomous functioning of SC, much in line with tumorous cells, and requires further exploration.
Macrophage senescence: a culmination of immunosenescence and cellular senescence?
The immune system reacts to exogenous and endogenous threats by initiating an inflammatory response. Macrophages are involved both during the onset of inflammation as well as its successful resolution. The recognition of a foreign particle prompts proinflammatory behavior in macrophages (also called classical activation or M1) characterized by increased production of inflammatory cytokines, respiratory burst, and phagocytosis (Orecchioni et al. 2019). To resolve the latent inflammation and debris, macrophages switch to an anti-inflammatory M2 phenotype by initiating reconstruction of damaged tissue and by prompting synthesis of extracellular matrix and cell growth (Rőszer 2015). As antigen-presenting cells, macrophages are involved in the regulation and differentiation of adaptive immune responses, while scavenger receptors on macrophages recognize and remove oxidized proteins/lipoproteins expressing damaged or apoptotic cells (Krieger and Herz 1994; Schliehe et al. 2011). These diverse functions of macrophages are severely hampered with age and are often attributed to the characteristic process of immunosenescence. For instance, it is known that M1/M2 polarization of macrophages is affected during aging, although the nature of this skewness is debatable. Age-dependent M1 to M2 polarization of macrophages has been observed in aging skeletal muscles (Cui et al. 2019) and during macular degeneration (Zandi et al. 2015), while we previously observed an anti-inflammatory phenotype in aged animals (Sharma et al. 2014). On the other hand, an age-dependent shift towards M1 pro-inflammatory state was also observed in aged mice which were ascribed to the degeneration of the enteric nervous system (Becker et al. 2018). These observed differences could be attributed to the heterogeneity and plasticity of macrophages, but regardless, any perturbations in the normal M1/M2 balance in macrophages may dysregulate the development of the host response, making the elderly more susceptible to inflammatory and infectious diseases (Mahbub et al. 2012; Wynn et al. 2013). Studies in experimental animals have also shown that macrophage phagocytic ability and respiratory burst (Linehan et al. 2014; Wong et al. 2017), TLR expression (Renshaw et al. 2002), response to antigenic stimulation (Ding et al. 1994), and LPS-induced cytokine production decline with age (Chelvarajan et al. 2006). Importantly, it was identified that an age-related decrease in phagocytic ability was not observed in bone marrow-derived macrophages and monocytes suggesting that age-associated changes in macrophage functions might not be cell-intrinsic, but could be related to external environmental factors (Linehan et al. 2014). Aging also results in a decreased antigen-presenting capacity of macrophages which may compromise the swiftness and the potency of the adaptive immune response. It has been observed that old mice exhibit impaired stimulation as well as expression of MHC class II molecules compared to macrophages isolated from young mice after stimulation with IFN-γ (Davila et al. 1990; Herrero et al. 2001). Aging has also been shown to reduce macrophage-mediated tissue repair and regeneration both in mice and humans. Danon et al. (1989) reported that local injection of peritoneal macrophages isolated from young mice could accelerate would healing in older animals. Age-related shifts in macrophage infiltration into wounds, alterations in chemokine content, and a concurrent decline in macrophage phagocytic function was also documented which may contribute to the delayed injury repair response during aging (Swift et al. 2001). A recent study showed that injured arteries in aging rats develop thicker neointimas, which were significantly correlated with a higher number of tissue macrophages and increased vascular IL-18 (Rodriguez-Menocal et al. 2014). Further, in vivo depletion of macrophages by clodronate liposomes ameliorated the vascular accumulation of IL-18 and the development of thicker neointimas (Rodriguez-Menocal et al. 2014).
Unlike immunosenescence, conclusive evidence of cellular senescence in macrophages is only beginning to be elucidated. Prior studies in T cells have shown that immune cells do exhibit the features of cellular senescence both in vitro and in vivo, while such work on macrophages remained scanty (Vallejo et al. 1999; Effros 2004; Chou and Effros 2013; Pawelec and Barnett 2016; Covre et al. 2020). However, using mice deficient in DNA repair protein Ercc1, a recent report has demonstrated that various immune cell populations, including the myeloid cells lineage, undergo characteristic features of cellular senescence such as increased expression of p16Inka4a, p21CIP1, and SASP which ultimately contribute to enhanced accumulation of SC in various murine tissues (Yousefzadeh et al. 2021). Previously, in vitro studies have shown that on exposure to external stressors, macrophages can develop senescence-like features including p21/p53 mediated cell cycle arrest (Fong et al. 2007; Nyunoya et al. 2003), altered morphology, and the development of SA-β-gal activity (Kim et al. 2015). Recently, we observed that peritoneal macrophages isolated from old mice exhibit heterogenous and elongated morphology, enhanced expression of cell cycle inhibitors p53/p21WAF1/p16Ink4a, and SA-β-gal activity as compared to macrophages isolated from younger animals (Kumar et al. 2020). In another study, an age-related increase in the characteristic marker of senescence p16Ink4a inhibited the normal phenotype of adipose tissue macrophages and contributed to type II diabetes risk (Fuentes et al. 2011). A negative correlation between Ki67 proliferation marker and cellular senescence marker SA-β-gal expression was observed in cultured macrophages suggesting that SA-β-gal activity labels macrophages with decreasing proliferation tendency (Holt and Grainger 2012). Another report noted that the majority of p16Ink4a and SA-β-gal positive cells in the tissues of aging mice were, in fact, macrophages, indicating a significant role of senescent macrophages which previously had been attributed to non-immune SC only (Hall et al. 2016). However, in their follow-up work, the same authors argued that p16Ink4a and SA-β-gal expression in macrophages could be unrelated to senescence, and may only be a part of a reversible response of macrophages to their physiological stimuli (Hall et al. 2017). These observations suggest an unexpected role of p16Ink4a expression in macrophages which warrants deeper characterization vis-à-vis other markers of cellular senescence. Notwithstanding this, another hallmark indicator of cellular senescence, i.e., telomere attrition, has also been observed in macrophages both during aging and disease. Analyses of bone marrow-derived macrophages showed strong age-dependent shortening of telomere length in aged (19–24-months-old) mice as compared to young (6-week-old) mice (Sebastián et al. 2009). Murine peritoneal macrophages isolated from first-generation telomerase reverse transcriptase-deficient mice significantly upregulated SA-β-gal activity and the expression of genes regulating cell cycle arrest such as p16, p21, and the retinoblastoma protein (Gizard et al. 2011). Mean telomere length in peripheral blood leukocytes was significantly shorter in sickle cell disease patients which directly correlated with the disease genotype and inflammation markers (Colella et al. 2017). Some studies have suggested that a characteristic SASP is also prevalent in senescent macrophages. A recent report has shown that LPS treated THP-1 macrophages develop features of cellular senescence and SASP as evident by expression of p53/p21/p16 cell cycle inhibitors and various SASP components (Wang et al. 2020). Using a diabetic mice model, it was observed that macrophages in diabetic kidneys showed archetypal features of cellular senescence as evident from increased mRNA expression pertaining to cell cycle arrest (p16/p21) and SASP (IL-6, TGF-β, PAI-1, MCP-1) suggesting that senescent macrophages are prevalent in vivo and could be a potential source of SASP in disease condition (Prattichizzo et al. 2018). Taken together, it is reasonable to envisage that both cellular senescence and immunosenescence can impact the different aspects of macrophage aging. However, either a conclusive correlation or a causative linkage between cellular senescence and immunosenescence in macrophages or other immune cells has not been established yet. Nonetheless, studies on telomere shortening have highlighted multiple negative effects on immune functions which could be related to some aspects of immunosenescence. For example, telomerase knockout mice developed exaggerated lung inflammation and increased mortality upon respiratory staphylococcal infection (Kang et al. 2018). Authors observed that telomere dysfunction caused macrophage mitochondrial abnormality, oxidative stress, and hyperactivation of the NLRP3 inflammasome, suggesting that loss of telomeres is sufficient to drive mitochondria-mediated redox imbalance, and thus contribute to macrophage functional incapacity which could be directly related to immunosenescence (Kang et al. 2018). Similarly, using telomerase knockout mice, it was observed that telomere loss is the cause for the enhanced oxidative stress, reduced Stat5a oxidation and phosphorylation, and, ultimately, for the impaired GM-CSF-dependent macrophage proliferation (Sebastián et al. 2009). It was also demonstrated that monocytes (but not lymphocytes) of aged type II diabetic patients had significantly lower mean telomere length and a significant inverse relationship between oxidative DNA damage and telomere length was observed in the diabetic group (Sampson et al. 2006). Another study showed a causative link between accumulating ROS and the development of senescent phenotype in macrophages (Singh et al. 2019). Thus, there appears to be a certain degree of causation between cellular senescence and immunosenescence, although, the data available are largely sporadic and preliminary in nature thereby necessitating further deeper and specific studies to completely understand the dichotomy of cellular senescence and immunosenescence in macrophage aging.
Interactions between macrophages and senescent cells
Macrophages are present throughout the body, wherein they reside as specialized tissue-resident cells and perform tissue-specific and niche-specific functions. As a result, different tissue-resident macrophages may be functionally distinct and respond differentially to effector functions (Minutti et al. 2017; Lacerda Mariano et al. 2020). Moreover, in terms of cellular senescence, recent studies have demonstrated that different aging tissues experience varying degrees of SC burden as the rate of cellular senescence is dependent on both the age as well as the type of tissue (Karin et al. 2019; Tuttle et al. 2020; Sharma et al. 2021). Thus, it is conceivable that dynamic interactions between specialized long-lived macrophages and different host tissues with varying degrees of cellular senescence, may differentially influence their functional capacity and/or the rate of cellular senescence (Fig. 2). Although these aspects are less explored, our previous ex vivo study showed that the secretory phenotype of senescent preadipocytes, but not proliferating preadipocytes, could induce a senescence-like phenotype in peritoneal macrophages isolated from young animals (but not from old animals) characterized by a strong SA-β-gal activity, cellular hypertrophy, increase in p16Ink4a expression and intracellular ROS production (Kumar et al. 2020). This implies that in a heterogeneous and dynamic in vivo system, the highly senescence-prone adipose tissue (Minamino et al. 2009; Sharma et al. 2021) could directly influence cellular senescence in adipose tissue macrophages. A recent study demonstrated that macrophages induced apoptosis in senescent fibroblasts and prevented their accumulation, however, chronic presence of fibroblast SASP factors downregulated macrophage-mediated apoptosis and phagocytosis thereby potentially suggesting that senescent tissues can directly affect macrophage functions which can contribute to increased tissue SC burden (Ogata et al. 2021). Similarly, another report identified that lysophosphatidylcholines expression is elevated in the phospholipids of senescent dermal fibroblasts which interfere with the toll-like receptor 2 and 6/CD36 signaling and subsequent phagocytic capacity in macrophages (Narzt et al. 2021). Exposure of macrophages to the secretome of senescent hepatocytes induced an M2 phenotype, while an M1 phenotype was observed in macrophages exposed to secretory factors of non-senescent hepatocytes (Sen et al. 2021). Similarly, exposure of macrophages to the conditioned media of senescent thyrocytes induced an anti-inflammatory M2 phenotype in macrophages showing high CD206 and low MHC II markers and upregulated CCL17 secretion which ultimately promoted tumor progression (Mazzoni et al. 2019).
In addition, a tantalizing interrelationship between myeloid-derived suppressor cells (MDSC), macrophage functions, and cellular senescence is also emerging in aging and disease (Ostrand-Rosenberg et al. 2012; Fulop et al. 2016; Salminen et al. 2018a, b). MDSC are a heterogeneous group of myeloid cells that originate from hematopoietic stem cells and perform immunosuppressive functions in the resolution of inflammation (Veglia et al. 2018). These cells are highly plastic and can also differentiate into mature myeloid cells such as macrophages and dendritic cells (Veglia et al. 2018). Since MDSC respond to inflammation, the chronic presence of a systemic and sterile inflammatory stimulus during aging (inflamm-aging) as well in other pathological conditions such as obesity, and hepatic steatosis can enhance the recruitment and proliferation of MDSC to affected tissues wherein they exert immunosuppressive effects on the innate and adaptive immune systems (Salminen et al. 2018a). This state is harmful as the prolonged existence of MDSC in tissues can not only disturb tissue homeostasis by impairing macrophage-mediated clearance of cell debris and tissue repair during injury (Veglia et al. 2018; Duong et al. 2021), but can also augment suppressive activity in macrophages (Ostrand-Rosenberg et al. 2012). It has been demonstrated that the numbers of MDSC increase in aged animal and human tissues, presumably due to persistent inflamm-aging, which results in enhanced T-cell suppression and thus compromised immunological state during aging (Enioutina et al. 2011; Verschoor et al. 2013; Flores et al. 2017). Further, the role of SASP factors secreted by senescent tissues in recruiting and augmenting the proliferation and activation of MDSC has also been envisaged (Salminen et al. 2018a). It was demonstrated that senescent stromal cells alone are sufficient to drive the localized increase in numbers of MDSC as well as their CD8 T cell inhibitory activity which was ultimately attributed to the SASP secretome of SC (Ruhland et al. 2016). Together, it is reasonable to assert that mutual dynamic interactions between SC and resident myeloid cells (including both macrophages and MDSC) can significantly shape the functional and phenotypical aspects of aging in these cells.
Immunometabolism and macrophage senescence
Understanding the metabolic regulation of immune functions, especially during aging, is an emerging area of research (Lee et al. 2021). To precisely perform their diverse functions, immune cells like macrophages need to quickly shift between various activation states which are subject to tight regulation by metabolic pathways and nutrient availability. For instance, upon activation, M1-like macrophages rapidly convert arginine to nitric oxide through inducible NO synthase activity, while M2 macrophages convert arginine to ornithine for effector functions (Galván-Peña and O’Neill 2014). Several studies suggest that nutrient signaling longevity pathways, such as mTOR, SIRT, and Insulin/IGF-1 are the key modulators and therapeutic targets of health and lifespan (Mazucanti et al. 2015). Aged macrophages generally show heightened inflammatory metabolic pathways, despite reduced phagocytic ability, antigen presentation, and mitochondrial dysfunction (van Beek et al. 2019; Lee et al. 2021). Using a mass spectrometry-based proteomic approach, age-dependent alterations in inflammatory signaling, mitochondrial function, and cellular metabolic pathways were observed in aged microglia cells, while a component of the mTORC2 complex was identified as a novel upstream regulator of several biological functions (Flowers et al. 2017). Rapamycin-induced inhibition of mTOR signaling accelerated diabetic encephalopathy in rats through the augmentation of macrophage autophagy (Wang et al. 2018). Knockdown of SIRT1 in the mouse macrophage RAW264.7 cell line and in intraperitoneal macrophages broadly activated the JNK and IKK inflammatory pathways, and increased LPS-stimulated TNFα secretion (Yoshizaki et al. 2010). On the other hand, overexpression of SIRT1 during bone marrow-derived macrophage differentiation increased their proliferative capacity and self-renewal (Imperatore et al. 2017). Sirtuin family of enzymes depend on the coenzyme NAD+ for their activation and function. NAD+ levels decline with age in different tissue types, including macrophages, which have been shown to increase inflammation and impair oxidative metabolism (Minhas et al. 2019). It is plausible that declining NAD+ levels in aged macrophages could also compromise SIRT activity that may negatively impact inflammatory homeostasis during aging (He et al. 2020). Interestingly, senescent macrophages have recently been implicated in the immunometabolism of NAD+ (Covarrubias et al. 2020). It was observed that NAD+ consuming CD38 + M1 macrophages with upregulated markers of senescence (p16/p21) and inflammation accumulated in adipose tissue which was primarily responsible for decreased NAD+ availability in tissues during aging, suggesting a causative relationship between CD38+ macrophages, NAD+ consumption, Sirtuins and aging (Covarrubias et al. 2020). In addition, M2 phenotype macrophages were identified as novel sources of IGF1, and ablation of IGF1 receptors from myeloid cells reduced phagocytosis, increased macrophages in adipose tissue, elevated adiposity, lowered energy expenditure, and led to insulin resistance in mice fed a high-fat diet indicating that IGF1 signaling shapes the macrophage-activation phenotype (Spadaro et al. 2017). A recent study showed the regulatory role of IGF1 signaling in cellular senescence and macrophage polarization wherein mice deficient for IGF1 receptors showed attenuated premature senescence in pneumocytes, reduced M2 macrophage polarization, and lung fibrosis (Chung et al. 2020). Together, it is evident that understanding the metabolic control of cellular senescence mediated by nutrient-sensing pathways is essential for completely comprehending the etiology and effects of macrophage senescence.
Unanswered questions and niche research areas
There are several lacunae in our present understanding of the causes and biological effects of cellular senescence in macrophages. This is of particular importance since tissue-resident macrophages, similar to memory T cells, are considered to be long-lived (Bain et al. 2016), and are thus liable to accumulate cellular and biochemical insults over time leading to genotoxic stress and the development of cellular senescence (Sedelnikova et al. 2004). Some of the key aspects to be investigated are (Fig. 3).
-
The extent and depth of in vivo cellular senescence in macrophages are unclear. This is especially significant since the presence and relevance of some of the established markers of cellular senescence, such as p16Ink4a expression and SA-β-gal activity, in macrophages, have been inconsistent and contentious. There is thus an urgent need to profile macrophages for age-dependent as well as tissue-dependent changes pertaining to the development of cellular senescence using the established markers of immune cell senescence (Zhou et al. 2021). Given the high heterogeneity amongst macrophages, using multi-omics approach at single-cell resolution would be a prudent approach.
-
Macrophage secretory phenotype changes with age, but whether it is related to the SASP of non-immune cells, or if senescent macrophage secretome contributes to inflamm-aging remains to be fully understood. In this context, whether senescent macrophages play any direct role in driving age-related inflammatory disorders such as type II diabetes or osteoarthritis is also unknown.
-
More information is required to understand the interrelationship between tissue-resident macrophages and SC. How SC or their secretome influence immunosenescence and/or cellular senescence in macrophages in vivo, and whether senescent macrophages can also impact the development of senescence in non-immune cells remains to be explored.
-
Immunometabolism of senescent macrophages is also poorly studied. Whether the longevity pathways play a similar role in macrophage senescence, and if these pathways could be therapeutic targets regulating macrophage functions during aging and disease remains to be elucidated.
-
Much information about the mechanisms and ligands of macrophage-mediated immunosurveillance is not known. It needs to be determined whether senescent macrophages preserve their capacity of immunosurveillance which can directly impact tissue SC accumulation.
-
Finally, nutraceuticals such as probiotics and polyphenols, as well as micronutrients are known to affect immunosenescence (Sharma et al. 2013; Wu et al. 2019) (Fig. 4), but whether the underlying mechanisms are relatable to cellular senescence is little understood (Sharma and Padwad 2020). In this regard, our previous work showed that green tea catechin EGCG can strongly attenuate the development of senescence-like features such as expression of p53/p21WAF1/p16Ink4a, and SA-β-gal activity in macrophages exposed to conditioned media of senescent preadipocytes (Kumar et al. 2020). This suggests that nutraceuticals can impact senescence induction in macrophages, although further elaborative studies are warranted.
Concluding remarks
Aging, cellular senescence, and immunosenescence appear to be intimately linked (Sharma and Padwad 2020). As most diverse and plastic immune cells, delineating the dichotomy of cellular senescence and immunosenescence in macrophages is necessary for comprehending the relationship between aging and immune functions. Evidence that cellular senescence is an active force driving the aging of macrophages and which may contribute to age-related pathologies is already emerging. In addition, it is very much plausible that senescent non-immune cells can significantly impair macrophage immune functions through paracrine effects, recruitment of MDSC, and augmentation of SC burden. This suggests an intricate relationship between host tissues and macrophages vis-à-vis cellular senescence which promises exciting research opportunities. In short, future studies must consider macrophages in the purview of cellular senescence which may ultimately provide an integrative and deeper understanding of organismal aging and the pathology of age-dependent diseases.
Abbreviations
- SC:
-
Senescent cells
- SASP:
-
Senescence-associated secretory phenotype
- SA-β-gal:
-
Senescence-associated β-galactosidase
- mTOR:
-
Mammalian target of rapamycin
- ROS:
-
Reactive oxygen species
- NAD+ :
-
Nicotinamide adenine dinucleotide
- MDSC:
-
Myeloid-derived suppressor cells
References
Aiello A, Farzaneh F, Candore G, Caruso C, Davinelli S, Gambino CM, Ligotti ME, Zareian N, Accardi G (2019) Immunosenescence and its hallmarks: how to oppose aging strategically? A review of potential options for therapeutic intervention. Front Immunol. https://doi.org/10.3389/fimmu.2019.02247
Aw D, Silva AB, Palmer DB (2007) Immunosenescence: emerging challenges for an ageing population. Immunology 120(4):435–446. https://doi.org/10.1111/j.1365-2567.2007.02555.x
Bain CC, Hawley CA, Garner H, Scott CL, Schridde A, Steers NJ, Mack M, Joshi A, Guilliams M, Mowat AM et al (2016) Long-lived self-renewing bone marrow-derived macrophages displace embryo-derived cells to inhabit adult serous cavities. Nat Commun 7:ncomms11852. https://doi.org/10.1038/ncomms11852
Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, Kirkland JL, van Deursen JM (2011) Clearance of p16ink4a-positive senescent cells delays ageing-associated disorders. Nature 479(7372):232–236. https://doi.org/10.1038/nature10600
Baker DJ, Childs BG, Durik M, Wijers ME, Sieben CJ, Zhong J, Saltness RA, Jeganathan KB, Verzosa GC, Pezeshki A et al (2016) Naturally occurring p16(ink4a)-positive cells shorten healthy lifespan. Nature 530(7589):184–189. https://doi.org/10.1038/nature16932
Becker L, Nguyen L, Gill J, Kulkarni S, Pasricha PJ, Habtezion A (2018) Age-dependent shift in macrophage polarisation causes inflammation-mediated degeneration of enteric nervous system. Gut 67(5):827–836. https://doi.org/10.1136/gutjnl-2016-312940
Bhatia-Dey N, Kanherkar RR, Stair SE, Makarev EO, Csoka AB (2016) Cellular senescence as the causal nexus of aging. Front Genet 7:13–13. https://doi.org/10.3389/fgene.2016.00013
Borghesan M, Hoogaars WMH, Varela-Eirin M, Talma N, Demaria M (2020) A senescence-centric view of aging: implications for longevity and disease. Trends Cell Biol 30(10):777–791. https://doi.org/10.1016/j.tcb.2020.07.002
Burton DGA, Stolzing A (2018) Cellular senescence: immunosurveillance and future immunotherapy. Ageing Res Rev 43:17–25. https://doi.org/10.1016/j.arr.2018.02.001
Cai Y, Zhou H, Zhu Y, Sun Q, Ji Y, Xue A, Wang Y, Chen W, Yu X, Wang L et al (2020) Elimination of senescent cells by β-galactosidase-targeted prodrug attenuates inflammation and restores physical function in aged mice. Cell Res 30(7):574–589. https://doi.org/10.1038/s41422-020-0314-9
Campisi J, Robert L (2014) Cell senescence: role in aging and age-related diseases. Interdiscip Top Gerontol 39:45–61. https://doi.org/10.1159/000358899
Carroll B, Korolchuk VI (2018) Nutrient sensing, growth and senescence. FEBS J 285(11):1948–1958. https://doi.org/10.1111/febs.14400
Chandrasekaran A, Idelchik MdPS, Melendez JA (2017) Redox control of senescence and age-related disease. Redox Biol 11:91–102. https://doi.org/10.1016/j.redox.2016.11.005
Chelvarajan RL, Liu Y, Popa D, Getchell ML, Getchell TV, Stromberg AJ, Bondada S (2006) Molecular basis of age-associated cytokine dysregulation in lps-stimulated macrophages. J Leukoc Biol 79(6):1314–1327. https://doi.org/10.1189/jlb.0106024
Chen K, Shen W, Zhang Z, Xiong F, Ouyang Q, Luo C (2020) Age-dependent decline in stress response capacity revealed by proteins dynamics analysis. Sci Rep 10(1):15211. https://doi.org/10.1038/s41598-020-72167-4
Childs BG, Durik M, Baker DJ, van Deursen JM (2015) Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med 21(12):1424–1435. https://doi.org/10.1038/nm.4000
Chou JP, Effros RB (2013) T cell replicative senescence in human aging. Curr Pharm Des 19(9):1680–1698. https://doi.org/10.2174/138161213805219711
Chung EJ, Kwon S, Reedy JL, White AO, Song JS, Hwang I, Chung JY, Ylaya K, Hewitt SM, Citrin DE (2020) Igf-1 receptor signaling regulates type II pneumocyte senescence and resulting macrophage polarization in lung fibrosis. Int J Radiat Oncol Biol Phys. https://doi.org/10.1016/j.ijrobp.2020.12.035
Colella MP, Santana BA, Conran N, Tomazini V, Costa FF, Calado RT, Saad STO (2017) Telomere length correlates with disease severity and inflammation in sickle cell disease. Rev Bras Hematol Hemoter 39(2):140–145. https://doi.org/10.1016/j.bjhh.2017.02.007
Coppé JP, Desprez PY, Krtolica A, Campisi J (2010) The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 5:99–118. https://doi.org/10.1146/annurev-pathol-121808-102144
Covarrubias AJ, Kale A, Perrone R, Lopez-Dominguez JA, Pisco AO, Kasler HG, Schmidt MS, Heckenbach I, Kwok R, Wiley CD et al (2020) Senescent cells promote tissue nad(+) decline during ageing via the activation of cd38(+) macrophages. Nat Metab 2(11):1265–1283. https://doi.org/10.1038/s42255-020-00305-3
Covre LP, De Maeyer RPH, Gomes DCO, Akbar AN (2020) The role of senescent t cells in immunopathology. Aging Cell 19(12):e13272. https://doi.org/10.1111/acel.13272
Cui C-Y, Driscoll RK, Piao Y, Chia CW, Gorospe M, Ferrucci L (2019) Skewed macrophage polarization in aging skeletal muscle. Aging Cell 18(6):e13032. https://doi.org/10.1111/acel.13032
Danon D, Kowatch MA, Roth GS (1989) Promotion of wound repair in old mice by local injection of macrophages. Proc Natl Acad Sci USA 86(6):2018–2020. https://doi.org/10.1073/pnas.86.6.2018
Davila DR, Edwards 3rd CK, Arkins S, Simon J, Kelley KW (1990) Interferon-gamma-induced priming for secretion of superoxide anion and tumor necrosis factor-alpha declines in macrophages from aged rats. FASEB J 4(11):2906–2911. https://doi.org/10.1096/fasebj.4.11.2165948
de Magalhães JP (2004) From cells to ageing: a review of models and mechanisms of cellular senescence and their impact on human ageing. Exp Cell Res 300(1):1–10. https://doi.org/10.1016/j.yexcr.2004.07.006
Del Giudice G, Goronzy JJ, Grubeck-Loebenstein B, Lambert P-H, Mrkvan T, Stoddard JJ, Doherty TM (2017) Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging. NPJ Aging Mech Dis 4(1):1. https://doi.org/10.1038/s41514-017-0020-0
Demaria M, Ohtani N, Youssef SA, Rodier F, Toussaint W, Mitchell JR, Laberge R-M, Vijg J, Van Steeg H, Dollé MET et al (2014) An essential role for senescent cells in optimal wound healing through secretion of pdgf-aa. Dev Cell 31(6):722–733. https://doi.org/10.1016/j.devcel.2014.11.012
DeSantis CE, Miller KD, Dale W, Mohile SG, Cohen HJ, Leach CR, Goding Sauer A, Jemal A, Siegel RL (2019) Cancer statistics for adults aged 85 years and older, 2019. CA Cancer J Clin 69(6):452–467. https://doi.org/10.3322/caac.21577
Ding A, Hwang S, Schwab R (1994) Effect of aging on murine macrophages. Diminished response to ifn-gamma for enhanced oxidative metabolism. J Immunol 153(5):2146–2152
Dodig S, Čepelak I, Pavić I (2019) Hallmarks of senescence and aging. Biochem Med 29(3):030501–030501. https://doi.org/10.11613/BM.2019.030501
Duong L, Radley HG, Lee B, Dye DE, Pixley FJ, Grounds MD, Nelson DJ, Jackaman C (2021) Macrophage function in the elderly and impact on injury repair and cancer. Immun Ageing 18(1):4. https://doi.org/10.1186/s12979-021-00215-2
Effros RB (2004) From Hayflick to Walford: the role of t cell replicative senescence in human aging. Exp Gerontol 39(6):885–890. https://doi.org/10.1016/j.exger.2004.03.004
Egashira M, Hirota Y, Shimizu-Hirota R, Saito-Fujita T, Haraguchi H, Matsumoto L, Matsuo M, Hiraoka T, Tanaka T, Akaeda S et al (2017) F4/80 + macrophages contribute to clearance of senescent cells in the mouse postpartum uterus. Endocrinology 158(7):2344–2353. https://doi.org/10.1210/en.2016-1886
Enioutina EY, Bareyan D, Daynes RA (2011) A role for immature myeloid cells in immune senescence. J Immunol 186(2):697. https://doi.org/10.4049/jimmunol.1002987
Flores RR, Clauson CL, Cho J, Lee BC, McGowan SJ, Baker DJ, Niedernhofer LJ, Robbins PD (2017) Expansion of myeloid-derived suppressor cells with aging in the bone marrow of mice through a nf-κb-dependent mechanism. Aging Cell 16(3):480–487. https://doi.org/10.1111/acel.12571
Flowers A, Bell-Temin H, Jalloh A, Stevens SM Jr, Bickford PC (2017) Proteomic anaysis of aged microglia: shifts in transcription, bioenergetics, and nutrient response. J Neuroinflamm 14(1):96. https://doi.org/10.1186/s12974-017-0840-7
Fong CC, Zhang Q, Shi YF, Wu RS, Fong WF, Yang M (2007) Effect of hypoxia on raw264.7 macrophages apoptosis and signaling. Toxicology 235(1–2):52–61. https://doi.org/10.1016/j.tox.2007.03.006
Fuentes L, Wouters K, Hannou SA, Cudejko C, Rigamonti E, Mayi TH, Derudas B, Pattou F, Chinetti-Gbaguidi G, Staels B et al (2011) Downregulation of the tumour suppressor p16ink4a contributes to the polarisation of human macrophages toward an adipose tissue macrophage (atm)-like phenotype. Diabetologia 54(12):3150–3156. https://doi.org/10.1007/s00125-011-2324-0
Fulop T, Dupuis G, Baehl S, Le Page A, Bourgade K, Frost E, Witkowski JM, Pawelec G, Larbi A, Cunnane S (2016) From inflamm-aging to immune-paralysis: a slippery slope during aging for immune-adaptation. Biogerontology 17(1):147–157
Galván-Peña S, O’Neill LAJ (2014) Metabolic reprograming in macrophage polarization. Front Immunol 5:420–420. https://doi.org/10.3389/fimmu.2014.00420
Gizard F, Heywood EB, Findeisen HM, Zhao Y, Jones KL, Cudejko C, Post GR, Staels B, Bruemmer D (2011) Telomerase activation in atherosclerosis and induction of telomerase reverse transcriptase expression by inflammatory stimuli in macrophages. Arterioscler Thromb Vasc Biol 31(2):245–252. https://doi.org/10.1161/ATVBAHA.110.219808
Hall BM, Balan V, Gleiberman AS, Strom E, Krasnov P, Virtuoso LP, Rydkina E, Vujcic S, Balan K, Gitlin I et al (2016) Aging of mice is associated with p16(ink4a)- and β-galactosidase-positive macrophage accumulation that can be induced in young mice by senescent cells. Aging (Albany N Y) 8(7):1294–1315. https://doi.org/10.18632/aging.100991
Hall BM, Balan V, Gleiberman AS, Strom E, Krasnov P, Virtuoso LP, Rydkina E, Vujcic S, Balan K, Gitlin II et al (2017) p16(ink4a) and senescence-associated β-galactosidase can be induced in macrophages as part of a reversible response to physiological stimuli. Aging 9(8):1867–1884. https://doi.org/10.18632/aging.101268
Hayflick L (1998) How and why we age. Exp Gerontol 33(7–8):639–653. https://doi.org/10.1016/s0531-5565(98)00023-0
Hayflick L, Moorhead PS (1961) The serial cultivation of human diploid cell strains. Exp Cell Res 25(3):585–621. https://doi.org/10.1016/0014-4827(61)90192-6
He M, Chiang H-H, Luo H, Zheng Z, Qiao Q, Wang L, Tan M, Ohkubo R, Mu W-C, Zhao S et al (2020) An acetylation switch of the nlrp3 inflammasome regulates aging-associated chronic inflammation and insulin resistance. Cell Metab 31(3):580–591.e585. https://doi.org/10.1016/j.cmet.2020.01.009
Hernandez-Segura A, Nehme J, Demaria M (2018) Hallmarks of cellular senescence. Trends Cell Biol 28(6):436–453. https://doi.org/10.1016/j.tcb.2018.02.001
Herrero C, Marqués L, Lloberas J, Celada A (2001) Ifn-gamma-dependent transcription of mhc class ii ia is impaired in macrophages from aged mice. J Clin Invest 107(4):485–493. https://doi.org/10.1172/JCI11696
Hickson LJ, Langhi Prata LGP, Bobart SA, Evans TK, Giorgadze N, Hashmi SK, Herrmann SM, Jensen MD, Jia Q, Jordan KL et al (2019) Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease. EBioMedicine 47:446–456. https://doi.org/10.1016/j.ebiom.2019.08.069
Holt DJ, Grainger DW (2012) Senescence and quiescence induced compromised function in cultured macrophages. Biomaterials 33(30):7497–7507. https://doi.org/10.1016/j.biomaterials.2012.06.099
Huo L, Magliano DJ, Rancière F, Harding JL, Nanayakkara N, Shaw JE, Carstensen B (2018) Impact of age at diagnosis and duration of type 2 diabetes on mortality in Australia 1997–2011. Diabetologia 61(5):1055–1063. https://doi.org/10.1007/s00125-018-4544-z
Iglesias-Ara A, Zenarruzabeitia O, Fernandez-Rueda J, Sánchez-Tilló E, Field SJ, Celada A, Zubiaga AM (2010) Accelerated DNA replication in e2f1- and e2f2-deficient macrophages leads to induction of the DNA damage response and p21cip1-dependent senescence. Oncogene 29(41):5579–5590. https://doi.org/10.1038/onc.2010.296
Imperatore F, Maurizio J, Vargas Aguilar S, Busch CJ, Favret J, Kowenz-Leutz E, Cathou W, Gentek R, Perrin P, Leutz A et al (2017) Sirt1 regulates macrophage self-renewal. EMBO J 36(16):2353–2372. https://doi.org/10.15252/embj.201695737
Irvine KM, Skoien R, Bokil NJ, Melino M, Thomas GP, Loo D, Gabrielli B, Hill MM, Sweet MJ, Clouston AD et al (2014) Senescent human hepatocytes express a unique secretory phenotype and promote macrophage migration. World J Gastroenterol 20(47):17851–17862. https://doi.org/10.3748/wjg.v20.i47.17851
Kale A, Sharma A, Stolzing A, Desprez P-Y, Campisi J (2020) Role of immune cells in the removal of deleterious senescent cells. Immun Ageing 17(1):16. https://doi.org/10.1186/s12979-020-00187-9
Kang TW, Yevsa T, Woller N, Hoenicke L, Wuestefeld T, Dauch D, Hohmeyer A, Gereke M, Rudalska R, Potapova A et al (2011) Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479(7374):547–551. https://doi.org/10.1038/nature10599
Kang Y, Zhang H, Zhao Y, Wang Y, Wang W, He Y, Zhang W, Zhang W, Zhu X, Zhou Y et al (2018) Telomere dysfunction disturbs macrophage mitochondrial metabolism and the nlrp3 inflammasome through the pgc-1α/tnfaip3 axis. Cell Rep 22(13):3493–3506. https://doi.org/10.1016/j.celrep.2018.02.071
Karin O, Agrawal A, Porat Z, Krizhanovsky V, Alon U (2019) Senescent cell turnover slows with age providing an explanation for the gompertz law. Nat Commun 10(1):5495. https://doi.org/10.1038/s41467-019-13192-4
Katzir I, Adler M, Karin O, Mendelsohn-Cohen N, Mayo A, Alon U (2021) Senescent cells and the incidence of age-related diseases. Aging Cell 20(3):e13314. https://doi.org/10.1111/acel.13314
Kay MM (1975) Mechanism of removal of senescent cells by human macrophages in situ. Proc Natl Acad Sci USA 72(9):3521–3525. https://doi.org/10.1073/pnas.72.9.3521
Kim K-H, Park B, Rhee D-K, Pyo S (2015) Acrylamide induces senescence in macrophages through a process involving atf3, ros, p38/jnk, and a telomerase-independent pathway. Chem Res Toxicol 28(1):71–86. https://doi.org/10.1021/tx500341z
Krieger M, Herz J (1994) Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and ldl receptor-related protein (lrp). Annu Rev Biochem 63:601–637. https://doi.org/10.1146/annurev.bi.63.070194.003125
Krishnamurthy J, Ramsey MR, Ligon KL, Torrice C, Koh A, Bonner-Weir S, Sharpless NE (2006) p16ink4a induces an age-dependent decline in islet regenerative potential. Nature 443(7110):453–457. https://doi.org/10.1038/nature05092
Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C, Yee H, Zender L, Lowe SW (2008) Senescence of activated stellate cells limits liver fibrosis. Cell 134(4):657–667. https://doi.org/10.1016/j.cell.2008.06.049
Kumar R, Sharma A, Padwad Y, Sharma R (2020) Preadipocyte secretory factors differentially modulate murine macrophage functions during aging which are reversed by the application of phytochemical egcg. Biogerontology 21(3):325–343. https://doi.org/10.1007/s10522-020-09861-3
Kumari R, Jat P (2021) Mechanisms of cellular senescence: cell cycle arrest and senescence associated secretory phenotype. Front Cell Dev Biol. https://doi.org/10.3389/fcell.2021.645593
Lacerda Mariano L, Rousseau M, Varet H, Legendre R, Gentek R, Saenz Coronilla J, Bajenoff M, Gomez Perdiguero E, Ingersoll MA (2020) Functionally distinct resident macrophage subsets differentially shape responses to infection in the bladder. Sci Adv. https://doi.org/10.1126/sciadv.abc5739
Lee K, Robbins PD, Camell CD (2021) Intersection of immunometabolism and immunosenescence during aging. Curr Opin Pharmacol 57:107–116. https://doi.org/10.1016/j.coph.2021.01.003
Lewis-McDougall FC, Ruchaya PJ, Domenjo-Vila E, Shin Teoh T, Prata L, Cottle BJ, Clark JE, Punjabi PP, Awad W, Torella D et al (2019) Aged-senescent cells contribute to impaired heart regeneration. Aging Cell 18(3):e12931. https://doi.org/10.1111/acel.12931
Linehan E, Dombrowski Y, Snoddy R, Fallon PG, Kissenpfennig A, Fitzgerald DC (2014) Aging impairs peritoneal but not bone marrow-derived macrophage phagocytosis. Aging Cell 13(4):699–708. https://doi.org/10.1111/acel.12223
López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G (2013) The hallmarks of aging. Cell 153(6):1194–1217. https://doi.org/10.1016/j.cell.2013.05.039
Ludlow AT, Spangenburg EE, Chin ER, Cheng W-H, Roth SM (2014) Telomeres shorten in response to oxidative stress in mouse skeletal muscle fibers. J Gerontol A 69(7):821–830. https://doi.org/10.1093/gerona/glt211
Lujambio A, Akkari L, Simon J, Grace D, Tschaharganeh DF, Bolden JE, Zhao Z, Thapar V, Joyce JA, Krizhanovsky V et al (2013) Non-cell-autonomous tumor suppression by p53. Cell 153(2):449–460. https://doi.org/10.1016/j.cell.2013.03.020
Maduro AT, Luís C, Soares R (2021) Ageing, cellular senescence and the impact of diet: an overview. Porto Biomed J 6(1):e120. https://doi.org/10.1097/j.pbj.0000000000000120
Mahbub S, Deburghgraeve CR, Kovacs EJ (2012) Advanced age impairs macrophage polarization. J Interferon Cytokine Res 32(1):18–26. https://doi.org/10.1089/jir.2011.0058
Mazucanti CH, Cabral-Costa JV, Vasconcelos AR, Andreotti DZ, Scavone C, Kawamoto EM (2015) Longevity pathways (mtor, sirt, insulin/igf-1) as key modulatory targets on aging and neurodegeneration. Curr Top Med Chem 15(21):2116–2138. https://doi.org/10.2174/1568026615666150610125715
Mazzoni M, Mauro G, Erreni M, Romeo P, Minna E, Vizioli MG, Belgiovine C, Rizzetti MG, Pagliardini S, Avigni R et al (2019) Senescent thyrocytes and thyroid tumor cells induce m2-like macrophage polarization of human monocytes via a pge2-dependent mechanism. J Exp Clin Cancer Res 38(1):208. https://doi.org/10.1186/s13046-019-1198-8
Mevorach D, Trahtemberg U, Krispin A, Attalah M, Zazoun J, Tabib A, Grau A, Verbovetski-Reiner I (2010) What do we mean when we write “senescence,“ “apoptosis,“ “necrosis,“ or “clearance of dying cells”? Ann N Y Acad Sci 1209:1–9. https://doi.org/10.1111/j.1749-6632.2010.05774.x
Minamino T, Orimo M, Shimizu I, Kunieda T, Yokoyama M, Ito T, Nojima A, Nabetani A, Oike Y, Matsubara H et al (2009) A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat Med 15(9):1082–1087. https://doi.org/10.1038/nm.2014
Minhas PS, Liu L, Moon PK, Joshi AU, Dove C, Mhatre S, Contrepois K, Wang Q, Lee BA, Coronado M et al (2019) Macrophage de novo nad(+) synthesis specifies immune function in aging and inflammation. Nat Immunol 20(1):50–63. https://doi.org/10.1038/s41590-018-0255-3
Minutti CM, Knipper JA, Allen JE, Zaiss DM (2017) Tissue-specific contribution of macrophages to wound healing. Semin Cell Dev Biol 61:3–11. https://doi.org/10.1016/j.semcdb.2016.08.006
Mogensen TH (2009) Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 22(2):240–273. https://doi.org/10.1128/CMR.00046-08
Nacarelli T, Torres C, Sell C (2016) Mitochondrial reactive oxygen species in cellular senescence. In: Rattan SIS, Hayflick L (eds) Cellular ageing and replicative senescence. Springer, Cham, pp 169–185
Narzt MS, Pils V, Kremslehner C, Nagelreiter IM, Schosserer M, Bessonova E, Bayer A, Reifschneider R, Terlecki-Zaniewicz L, Waidhofer-Söllner P et al (2021) Epilipidomics of senescent dermal fibroblasts identify lysophosphatidylcholines as pleiotropic senescence-associated secretory phenotype (sasp) factors. J Invest Dermatol 141(4s):993–1006.e1015. https://doi.org/10.1016/j.jid.2020.11.020
Nyunoya T, Powers LS, Yarovinsky TO, Butler NS, Monick MM, Hunninghake GW (2003) Hyperoxia induces macrophage cell cycle arrest by adhesion-dependent induction of p21cip1 and activation of the retinoblastoma protein. J Biol Chem 278(38):36099–36106. https://doi.org/10.1074/jbc.M304370200
Ogata Y, Yamada T, Hasegawa S, Sanada A, Iwata Y, Arima M, Nakata S, Sugiura K, Akamatsu H (2021) Sasp-induced macrophage dysfunction may contribute to accelerated senescent fibroblast accumulation in the dermis. Exp Dermatol 30(1):84–91. https://doi.org/10.1111/exd.14205
Ogrodnik M, Evans SA, Fielder E, Victorelli S, Kruger P, Salmonowicz H, Weigand BM, Patel AD, Pirtskhalava T, Inman CL et al (2021) Whole-body senescent cell clearance alleviates age-related brain inflammation and cognitive impairment in mice. Aging Cell 20(2):e13296. https://doi.org/10.1111/acel.13296
Olivieri F, Prattichizzo F, Grillari J, Balistreri CR (2018) Cellular senescence and inflammaging in age-related diseases. Mediat Inflamm. https://doi.org/10.1155/2018/9076485
Orecchioni M, Ghosheh Y, Pramod AB, Ley K (2019) Macrophage polarization: different gene signatures in m1(lps+) vs. classically and m2(lps–) vs. alternatively activated macrophages. Front Immunol. https://doi.org/10.3389/fimmu.2019.01084
Ostrand-Rosenberg S, Sinha P, Beury DW, Clements VK (2012) Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression. Semin Cancer Biol 22:275–281. https://doi.org/10.1016/j.semcancer.2012.01.011
Ovadya Y, Landsberger T, Leins H, Vadai E, Gal H, Biran A, Yosef R, Sagiv A, Agrawal A, Shapira A et al (2018) Impaired immune surveillance accelerates accumulation of senescent cells and aging. Nat Commun 9(1):5435. https://doi.org/10.1038/s41467-018-07825-3
Palmer AK, Xu M, Zhu Y, Pirtskhalava T, Weivoda MM, Hachfeld CM, Prata LG, van Dijk TH, Verkade E, Casaclang-Verzosa G et al (2019) Targeting senescent cells alleviates obesity-induced metabolic dysfunction. Aging Cell 18(3):e12950. https://doi.org/10.1111/acel.12950
Pawelec G, Barnett Y (2016) Ageing and senescence in immune cells in vitro and in vivo. In: Rattan SIS, Hayflick L (eds) Cellular ageing and replicative senescence. Springer, Cham, pp 85–95
Pawelec G, Bronikowski A, Cunnane SC, Ferrucci L, Franceschi C, Fülöp T, Gaudreau P, Gladyshev VN, Gonos ES, Gorbunova V et al (2020) The conundrum of human immune system “senescence”. Mech Ageing Dev 192:111357. https://doi.org/10.1016/j.mad.2020.111357
Pereira BI, Devine OP, Vukmanovic-Stejic M, Chambers ES, Subramanian P, Patel N, Virasami A, Sebire NJ, Kinsler V, Valdovinos A et al (2019) Senescent cells evade immune clearance via hla-e-mediated nk and cd8 + t cell inhibition. Nat Commun 10(1):2387. https://doi.org/10.1038/s41467-019-10335-5
Prata LGPL, Ovsyannikova IG, Tchkonia T, Kirkland JL (2018) Senescent cell clearance by the immune system: emerging therapeutic opportunities. Semin Immunol 40:101275. https://doi.org/10.1016/j.smim.2019.04.003
Prattichizzo F, De Nigris V, Mancuso E, Spiga R, Giuliani A, Matacchione G, Lazzarini R, Marcheselli F, Recchioni R, Testa R et al (2018) Short-term sustained hyperglycaemia fosters an archetypal senescence-associated secretory phenotype in endothelial cells and macrophages. Redox Biol 15:170–181. https://doi.org/10.1016/j.redox.2017.12.001
Rattan SIS (2016) Origins of the hayflick system, the phenomenon and the limit. In: Rattan SIS, Hayflick L (eds) Cellular ageing and replicative senescence. Springer, Cham, pp 3–14
Renshaw M, Rockwell J, Engleman C, Gewirtz A, Katz J, Sambhara S (2002) Cutting edge: impaired toll-like receptor expression and function in aging. J Immunol 169(9):4697–4701. https://doi.org/10.4049/jimmunol.169.9.4697
Robinson AR, Yousefzadeh MJ, Rozgaja TA, Wang J, Li X, Tilstra JS, Feldman CH, Gregg SQ, Johnson CH, Skoda EM et al (2018) Spontaneous DNA damage to the nuclear genome promotes senescence, redox imbalance and aging. Redox Biol 17:259–273. https://doi.org/10.1016/j.redox.2018.04.007
Rodriguez-Menocal L, Faridi MH, Martinez L, Shehadeh LA, Duque JC, Wei Y, Mesa A, Pena A, Gupta V, Pham SM et al (2014) Macrophage-derived IL-18 and increased fibrinogen deposition are age-related inflammatory signatures of vascular remodeling. Am J Physiol Heart Circ Physiol 306(5):H641–H653. https://doi.org/10.1152/ajpheart.00641.2013
Rőszer T (2015) Understanding the mysterious M2 macrophage through activation markers and effector mechanisms. Mediat Inflamm. https://doi.org/10.1155/2015/816460
Ruhland MK, Loza AJ, Capietto A-H, Luo X, Knolhoff BL, Flanagan KC, Belt BA, Alspach E, Leahy K, Luo J et al (2016) Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis. Nat Commun 7(1):11762. https://doi.org/10.1038/ncomms11762
Sagiv A, Burton DGA, Moshayev Z, Vadai E, Wensveen F, Ben-Dor S, Golani O, Polic B, Krizhanovsky V (2016) Nkg2d ligands mediate immunosurveillance of senescent cells. Aging 8(2):328–344. https://doi.org/10.18632/aging.100897
Salminen A, Kauppinen A, Kaarniranta K (2018a) Myeloid-derived suppressor cells (mdsc): an important partner in cellular/tissue senescence. Biogerontology 19(5):325–339. https://doi.org/10.1007/s10522-018-9762-8
Salminen A, Kaarniranta K, Kauppinen A (2018b) The role of myeloid-derived suppressor cells (MDSC) in the inflammaging process. Ageing Res Rev 48:1–10. https://doi.org/10.1016/j.arr.2018.09.001
Sampson MJ, Winterbone MS, Hughes JC, Dozio N, Hughes DA (2006) Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes. Diabetes Care 29(2):283–289. https://doi.org/10.2337/diacare.29.02.06.dc05-1715
Schliehe C, Redaelli C, Engelhardt S, Fehlings M, Mueller M, van Rooijen N, Thiry M, Hildner K, Weller H, Groettrup M (2011) Cd8- dendritic cells and macrophages cross-present poly(d,l-lactate-co-glycolate) acid microsphere-encapsulated antigen in vivo. J Immunol 187(5):2112–2121. https://doi.org/10.4049/jimmunol.1002084
Sebastián C, Herrero C, Serra M, Lloberas J, Blasco MA, Celada A (2009) Telomere shortening and oxidative stress in aged macrophages results in impaired stat5a phosphorylation. J Immunol 183(4):2356–2364. https://doi.org/10.4049/jimmunol.0901131
Sedelnikova OA, Horikawa I, Zimonjic DB, Popescu NC, Bonner WM, Barrett JC (2004) Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks. Nat Cell Biol 6(2):168–170. https://doi.org/10.1038/ncb1095
Sen B, Aggarwal S, Nath R, Sehgal R, Rastogi A, Trehanpati N, Ramakrishna G (2021) Secretome of senescent hepatoma cells modulate macrophage polarization and neutrophil extracellular traps formation. bioRxiv. https://doi.org/10.1101/2020.12.30.423905
Sharma R, Padwad Y (2020) Perspectives of the potential implications of polyphenols in influencing the interrelationship between oxi-inflammatory stress, cellular senescence and immunosenescence during aging. Trends Food Sci Technol 98:41–52. https://doi.org/10.1016/j.tifs.2020.02.004
Sharma R, Kapila R, Kapila S (2013) Probiotics as anti-immunosenescence agents. Food Rev Int 29(2):201–216. https://doi.org/10.1080/87559129.2012.751547
Sharma R, Kapila R, Haq MR, Salingati V, Kapasiya M, Kapila S (2014) Age-associated aberrations in mouse cellular and humoral immune responses. Aging Clin Exp Res 26(4):353–362. https://doi.org/10.1007/s40520-013-0190-y
Sharma R, Kumar R, Sharma A, Goel A, Padwad Y (2021) Long term consumption of green tea egcg enhances healthspan and lifespan in mice by mitigating multiple aspects of cellular senescence in mitotic and post-mitotic tissues, gut dysbiosis and immunosenescence. bioRxiv. https://doi.org/10.1101/2021.01.01.425058
Singh MV, Kotla S, Le NT, Ae Ko K, Heo KS, Wang Y, Fujii Y, Thi Vu H, McBeath E, Thomas TN et al (2019) Senescent phenotype induced by p90rsk-nrf2 signaling sensitizes monocytes and macrophages to oxidative stress in hiv-positive individuals. Circulation 139(9):1199–1216. https://doi.org/10.1161/circulationaha.118.036232
Solana R, Tarazona R, Gayoso I, Lesur O, Dupuis G, Fulop T (2012) Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. Semin Immunol 24(5):331–341. https://doi.org/10.1016/j.smim.2012.04.008
Spadaro O, Camell CD, Bosurgi L, Nguyen KY, Youm YH, Rothlin CV, Dixit VD (2017) Igf1 shapes macrophage activation in response to immunometabolic challenge. Cell Rep 19(2):225–234. https://doi.org/10.1016/j.celrep.2017.03.046
Swift ME, Burns AL, Gray KL, DiPietro LA (2001) Age-related alterations in the inflammatory response to dermal injury. J Invest Dermatol 117(5):1027–1035. https://doi.org/10.1046/j.0022-202x.2001.01539.x
Tuttle CSL, Waaijer MEC, Slee-Valentijn MS, Stijnen T, Westendorp R, Maier AB (2020) Cellular senescence and chronological age in various human tissues: a systematic review and meta-analysis. Aging Cell 19(2):e13083. https://doi.org/10.1111/acel.13083
Vallejo AN, Brandes JC, Weyand CM, Goronzy JJ (1999) Modulation of cd28 expression: distinct regulatory pathways during activation and replicative senescence. J Immunol 162(11):6572–6579
van Beek AA, Van den Bossche J, Mastroberardino PG, de Winther MPJ, Leenen PJM (2019) Metabolic alterations in aging macrophages: ingredients for inflammaging? Trends Immunol 40(2):113–127. https://doi.org/10.1016/j.it.2018.12.007
Veglia F, Perego M, Gabrilovich D (2018) Myeloid-derived suppressor cells coming of age. Nat Immunol 19(2):108–119. https://doi.org/10.1038/s41590-017-0022-x
Verschoor CP, Johnstone J, Millar J, Dorrington MG, Habibagahi M, Lelic A, Loeb M, Bramson JL, Bowdish DM (2013) Blood cd33(+)hla-dr(-) myeloid-derived suppressor cells are increased with age and a history of cancer. J Leukoc Biol 93(4):633–637. https://doi.org/10.1189/jlb.0912461
Vĕtvicka V, Tlaskalová-Hogenová H, Pospísil M (1985) Impaired antigen presenting function of macrophages from aged mice. Immunol Invest 14(2):105–114. https://doi.org/10.3109/08820138509042005
Vicente R, Mausset-Bonnefont A-L, Jorgensen C, Louis-Plence P, Brondello J-M (2016) Cellular senescence impact on immune cell fate and function. Aging Cell 15(3):400–406. https://doi.org/10.1111/acel.12455
von Zglinicki T (2002) Oxidative stress shortens telomeres. Trends Biochem Sci 27(7):339–344. https://doi.org/10.1016/s0968-0004(02)02110-2
Wang B, Zhong Y, Li Q, Cui L, Huang G (2018) Autophagy of macrophages is regulated by pi3k/akt/mtor signalling in the development of diabetic encephalopathy. Aging (Albany N Y) 10(10):2772–2782. https://doi.org/10.18632/aging.101586
Wang H, Fu H, Zhu R, Wu X, Ji X, Li X, Jiang H, Lin Z, Tang X, Sun S et al (2020) Brd4 contributes to lps-induced macrophage senescence and promotes progression of atherosclerosis-associated lipid uptake. Aging 12(10):9240–9259. https://doi.org/10.18632/aging.103200
Wijshake T, van Deursen JMA (2016) Targeting senescent cells to improve human health. In: Rattan SIS, Hayflick L (eds) Cellular ageing and replicative senescence. Springer, Cham, pp 313–343
Wissler Gerdes EO, Zhu Y, Tchkonia T, Kirkland JL (2020) Discovery, development, and future application of senolytics: theories and predictions. FEBS J 287(12):2418–2427. https://doi.org/10.1111/febs.15264
Wong CK, Smith CA, Sakamoto K, Kaminski N, Koff JL, Goldstein DR (2017) Aging impairs alveolar macrophage phagocytosis and increases influenza-induced mortality in mice. J Immunol 199(3):1060–1068. https://doi.org/10.4049/jimmunol.1700397
Wu D, Lewis ED, Pae M, Meydani SN (2019) Nutritional modulation of immune function: analysis of evidence, mechanisms, and clinical relevance. Front Immunol. https://doi.org/10.3389/fimmu.2018.03160
Wynn TA, Chawla A, Pollard JW (2013) Macrophage biology in development, homeostasis and disease. Nature 496(7446):445–455. https://doi.org/10.1038/nature12034
Xu M, Pirtskhalava T, Farr JN, Weigand BM, Palmer AK, Weivoda MM, Inman CL, Ogrodnik MB, Hachfeld CM, Fraser DG et al (2018) Senolytics improve physical function and increase lifespan in old age. Nat Med 24(8):1246–1256. https://doi.org/10.1038/s41591-018-0092-9
Xu W, Wong G, Hwang YY, Larbi A (2020) The untwining of immunosenescence and aging. Semin Immunopathol 42(5):559–572. https://doi.org/10.1007/s00281-020-00824-x
Yoshizaki T, Schenk S, Imamura T, Babendure JL, Sonoda N, Bae EJ, Oh DY, Lu M, Milne JC, Westphal C et al (2010) Sirt1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. Am J Physiol Endocrinol Metab 298(3):E419–E428. https://doi.org/10.1152/ajpendo.00417.2009
Yousefzadeh MJ, Flores RR, Zhu Y, Schmiechen ZC, Brooks RW, Trussoni CE, Cui Y, Angelini L, Lee K-A, McGowan SJ et al (2021) An aged immune system drives senescence and ageing of solid organs. Nature. https://doi.org/10.1038/s41586-021-03547-7
Zandi S, Nakao S, Chun K-H, Fiorina P, Sun D, Arita R, Zhao M, Kim E, Schueller O, Campbell S et al (2015) Rock-isoform-specific polarization of macrophages associated with age-related macular degeneration. Cell Rep 10(7):1173–1186. https://doi.org/10.1016/j.celrep.2015.01.050
Zhang Y, Unnikrishnan A, Deepa SS, Liu Y, Li Y, Ikeno Y, Sosnowska D, Van Remmen H, Richardson A (2017) A new role for oxidative stress in aging: the accelerated aging phenotype in sod1(-/)(-) mice is correlated to increased cellular senescence. Redox Biol 11:30–37. https://doi.org/10.1016/j.redox.2016.10.014
Zhou D, Borsa M, Simon AK (2021) Hallmarks and detection techniques of cellular senescence and cellular ageing in immune cells. Aging Cell 20(2):e13316. https://doi.org/10.1111/acel.13316
Funding
This work was supported by a grant from the Department of Science & Technology, Government of India under the INSPIRE Faculty scheme (Grant No. IFA17-LSPA79).
Conflict of interestThe authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sharma, R. Perspectives on the dynamic implications of cellular senescence and immunosenescence on macrophage aging biology. Biogerontology 22, 571–587 (2021). https://doi.org/10.1007/s10522-021-09936-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10522-021-09936-9